Skip to main content

Paresthesia-Free Fast-Acting Subperception (FAST) Study

Active, not recruiting · Not applicable · NCT04618471

Conditions: Chronic Pain

At a glance

Research payments reported, 2025
$397,604
U.S. investigators named
11
Sites paid
11
Planned or actual enrollment
177

About the trial

Sponsor
Boston Scientific Corporation
Tested
Boston Scientific WaveWriter SCS System (device)
Dates
Started 2021-02-10; completion 2029-03
Results posted
Yes

Study to evaluate the effectiveness of FAST-SCS (fast-acting paresthesia-free therapy) and additional SCS therapy options in patients with chronic pain using Boston Scientific WaveWriter SCS Systems.

From ClinicalTrials.gov, last updated 2026-10-09. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Boston Scientific Corporation reported $397,604 in research payments for this study in 2025 (126 payments).

Products named: Precision

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Pcpmg Clinical Research Unit LLC $147,737
  • The Orthopaedic Institute $63,165
  • Helen Hayes Hospital, NY $33,589
  • Biomedical Research Alliance of New York $32,012
  • Center for Clin Research $26,730
  • Dbps Research LLC $22,411
  • South Lake PAin Institute $20,151
  • Vitamed Research LLC $17,507
  • Willis Knighton River Cities Clinical Research Center $16,310
  • Neurosurgery Foundation at Goodman Campbell $11,078
  • Pacific Sports and Interventional Spine Physicians LLC $6,914

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.